Top compounds associated with response to KLRC3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.025 0.4
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.032 0.4
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA avicin D CTRPv2 pan-cancer AAC -0.045 0.4
mRNA B02 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Bortezomib gCSI pan-cancer AAC -0.05 0.4
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV